93 related articles for article (PubMed ID: 16959548)
21. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway.
Lim DS; Kim ST; Xu B; Maser RS; Lin J; Petrini JH; Kastan MB
Nature; 2000 Apr; 404(6778):613-7. PubMed ID: 10766245
[TBL] [Abstract][Full Text] [Related]
22. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products.
Zhao S; Weng YC; Yuan SS; Lin YT; Hsu HC; Lin SC; Gerbino E; Song MH; Zdzienicka MZ; Gatti RA; Shay JW; Ziv Y; Shiloh Y; Lee EY
Nature; 2000 May; 405(6785):473-7. PubMed ID: 10839544
[TBL] [Abstract][Full Text] [Related]
23. Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL.
Luo L; Lu FM; Hart S; Foroni L; Rabbani H; Hammarström L; Yuille MR; Catovsky D; Webster AD; Vorechovský I
Cancer Res; 1998 Jun; 58(11):2293-7. PubMed ID: 9622061
[TBL] [Abstract][Full Text] [Related]
24. Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.
Spring K; Ahangari F; Scott SP; Waring P; Purdie DM; Chen PC; Hourigan K; Ramsay J; McKinnon PJ; Swift M; Lavin MF
Nat Genet; 2002 Sep; 32(1):185-90. PubMed ID: 12195425
[TBL] [Abstract][Full Text] [Related]
25. ATM signaling and genomic stability in response to DNA damage.
Lavin MF; Birrell G; Chen P; Kozlov S; Scott S; Gueven N
Mutat Res; 2005 Jan; 569(1-2):123-32. PubMed ID: 15603757
[TBL] [Abstract][Full Text] [Related]
26. Nbs1 promotes ATM dependent phosphorylation events including those required for G1/S arrest.
Girard PM; Riballo E; Begg AC; Waugh A; Jeggo PA
Oncogene; 2002 Jun; 21(27):4191-9. PubMed ID: 12082606
[TBL] [Abstract][Full Text] [Related]
27. Effect of TERT and ATM on gene expression profiles in human fibroblasts.
Baross A; Schertzer M; Zuyderduyn SD; Jones SJ; Marra MA; Lansdorp PM
Genes Chromosomes Cancer; 2004 Apr; 39(4):298-310. PubMed ID: 14978791
[TBL] [Abstract][Full Text] [Related]
28. Iron deficiency can upregulate expression of transferrin receptor at both the mRNA and protein level.
Tong X; Kawabata H; Koeffler HP
Br J Haematol; 2002 Feb; 116(2):458-64. PubMed ID: 11841452
[TBL] [Abstract][Full Text] [Related]
29. Dose response of gamma rays and iron nuclei for induction of chromosomal aberrations in normal and repair-deficient cell lines.
George KA; Hada M; Jackson LJ; Elliott T; Kawata T; Pluth JM; Cucinotta FA
Radiat Res; 2009 Jun; 171(6):752-63. PubMed ID: 19580482
[TBL] [Abstract][Full Text] [Related]
30. Treatment with a catalytic antioxidant corrects the neurobehavioral defect in ataxia-telangiectasia mice.
Browne SE; Roberts LJ; Dennery PA; Doctrow SR; Beal MF; Barlow C; Levine RL
Free Radic Biol Med; 2004 Apr; 36(7):938-42. PubMed ID: 15019978
[TBL] [Abstract][Full Text] [Related]
31. Ataxia-telangiectasia mutated (ATM) deficiency decreases reprogramming efficiency and leads to genomic instability in iPS cells.
Kinoshita T; Nagamatsu G; Kosaka T; Takubo K; Hotta A; Ellis J; Suda T
Biochem Biophys Res Commun; 2011 Apr; 407(2):321-6. PubMed ID: 21385566
[TBL] [Abstract][Full Text] [Related]
32. Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.
Micol R; Ben Slama L; Suarez F; Le Mignot L; Beauté J; Mahlaoui N; Dubois d'Enghien C; Laugé A; Hall J; Couturier J; Vallée L; Delobel B; Rivier F; Nguyen K; Billette de Villemeur T; Stephan JL; Bordigoni P; Bertrand Y; Aladjidi N; Pedespan JM; Thomas C; Pellier I; Koenig M; Hermine O; Picard C; Moshous D; Neven B; Lanternier F; Blanche S; Tardieu M; Debré M; Fischer A; Stoppa-Lyonnet D;
J Allergy Clin Immunol; 2011 Aug; 128(2):382-9.e1. PubMed ID: 21665257
[TBL] [Abstract][Full Text] [Related]
33. Role for ATM in DNA damage-induced phosphorylation of BRCA1.
Gatei M; Scott SP; Filippovitch I; Soronika N; Lavin MF; Weber B; Khanna KK
Cancer Res; 2000 Jun; 60(12):3299-304. PubMed ID: 10866324
[TBL] [Abstract][Full Text] [Related]
34. Distal spinal muscular atrophy as a major feature in adult-onset ataxia telangiectasia.
Hiel JA; van Engelen BG; Weemaes CM; Broeks A; Verrips A; ter Laak H; Vingerhoets HM; van den Heuvel LP; Lammens M; Gabreëls FJ; Last JI; Taylor AM
Neurology; 2006 Jul; 67(2):346-9. PubMed ID: 16864838
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone supplementation increased latency to tumourigenesis in Atm-deficient mice.
Schubert R; Schmitz N; Pietzner J; Tandi C; Theisen A; Dresel R; Christmann M; Zielen S
Growth Factors; 2009 Oct; 27(5):265-73. PubMed ID: 19626507
[TBL] [Abstract][Full Text] [Related]
36. The Ataxia telangiectasia gene product is required for oxidative stress-induced G1 and G2 checkpoint function in human fibroblasts.
Shackelford RE; Innes CL; Sieber SO; Heinloth AN; Leadon SA; Paules RS
J Biol Chem; 2001 Jun; 276(24):21951-9. PubMed ID: 11290740
[TBL] [Abstract][Full Text] [Related]
37. Effects of iron chelators and glutathione depletion on the induction and repair of chromosomal aberrations by tert-butyl hydroperoxide in cultured Chinese hamster cells.
Ochi T
Mutat Res; 1989 Aug; 213(2):243-8. PubMed ID: 2761558
[TBL] [Abstract][Full Text] [Related]
38. Impact of G₂ checkpoint defect on centromeric instability.
Deng W; Tsao SW; Mak GW; Tsang CM; Ching YP; Guan XY; Huen MS; Cheung AL
Oncogene; 2011 Mar; 30(11):1281-9. PubMed ID: 21057540
[TBL] [Abstract][Full Text] [Related]
39. Synergism between iron chelators and complement for bactericidal activity.
Rivier D; Page N; Isliker H
Ann Immunol (Paris); 1983; 134C(1):25-30. PubMed ID: 6344748
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of protection by the flavonoids, quercetin and rutin, against tert-butylhydroperoxide- and menadione-induced DNA single strand breaks in Caco-2 cells.
Aherne SA; O'Brien NM
Free Radic Biol Med; 2000 Sep; 29(6):507-14. PubMed ID: 11025194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
